Fiche centre
Duke University
Durham — United States
Essais liés20clinical trials
VilleDurhamlocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05747924
Essais cliniques associés
20| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Irreversible Electroporation | Cancer | Non applicable | NCT04972097 | PRESERVE — Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue | COMPLETED |
| TRI-611 | Cancer | Phase 1/2 | NCT07491497 | A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC | RECRUITING |
| ADRC Clinical Cohort (Alzheimer's Disease) | Alzheimer | À vérifier | NCT06703541 | ADRC Clinical Cohort (Alzheimer's Disease) | RECRUITING |
| MN-166 | Sclérose latérale amyotrophique | À vérifier | NCT06743776 | SEANOBI-ALS — Scalable Expanded Access With Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS | NO_LONGER_AVAILABLE |
| CAPTURE-ALS — Clinical Procedures to Support Research in ALS | Sclérose latérale amyotrophique | À vérifier | NCT03489278 | CAPTURE-ALS — Clinical Procedures to Support Research in ALS | RECRUITING |
| Previous receipt of the Minder System (implantable continuous electroencephalographic (EEG) monitoring (iCEM) system) | Épilepsie | À vérifier | NCT07110454 | DETECT LTFU — Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up | RECRUITING |
| Receipt of the Minder System (implantable sub-scalp continuous electroencephalographic (EEG) monitoring (iCEM) system) | Épilepsie | Non applicable | NCT07110337 | DETECT — Diagnosing Epilepsy To EffeCT Change | RECRUITING |
| AOC 1020 | Myopathies | Phase 2 | NCT06547216 | FORTITUDE-OLE — Phase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) | ACTIVE_NOT_RECRUITING |
| AOC 1020 | Myopathies | Phase 1/2 | NCT05747924 | FORTITUDE — Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) | COMPLETED |
| neuromodulation for episodic migraine headache | Migraine | Non applicable | NCT01899040 | A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache | COMPLETED |
| ASSESS ALL ALS Study | Sclérose latérale amyotrophique | À vérifier | NCT06578195 | ASSESS ALL ALS Study | RECRUITING |
| PREVENT ALL ALS Study | Sclérose latérale amyotrophique | À vérifier | NCT06581861 | PREVENT ALL ALS Study | RECRUITING |
| Mycophenolate Mofetil | Myasthénie | À vérifier | NCT03490539 | PROMISE-MG — Disease-Modifying Treatments for Myasthenia Gravis | COMPLETED |
| AOC-1020 | Myopathies | Phase 3 | NCT07038200 | FORTITUDE-3 — A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD | RECRUITING |
| XEN1101 | Épilepsie | Phase 3 | NCT05718817 | X-TOLE4 — An Open-label Study of XEN1101 in Epilepsy | ENROLLING_BY_INVITATION |
| Anti-hypertensive therapy | Hypertension | Phase 4 | NCT02299414 | Chronic Hypertension and Pregnancy (CHAP) Project | COMPLETED |
| Celecoxib | Sclérose latérale amyotrophique | Phase 2 | NCT00355576 | Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis | COMPLETED |
| PiCASO — Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions | Lupus | NA | NCT03938324 | PiCASO — Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions | COMPLETED |
| Zilucoplan | Sclérose latérale amyotrophique | Phase 2/3 | NCT04297683 | HEALEY ALS Platform Trial - Master Protocol | ACTIVE_NOT_RECRUITING |
| Evaluation of Advanced Imaging and Visualization for Clinical Deep Brain Stimulation | Parkinson | À vérifier | NCT06191874 | Evaluation of Advanced Imaging and Visualization for Clinical Deep Brain Stimulation | COMPLETED |